Description
Gemcitabine is used to treat locally advanced or metastatic bladder cancer, in combination with cisplatin.
- Gemcitabine is used to treat locally advanced or metastatic pancreatic cancer.
How to use:
- Gemcitabine can only be prescribed by physicians with expertise in the use of anti-cancer drugs.
- Gemcitabine is well tolerated during infusion and the patient can walk (not lie down).
Caution & Warnings:
- Hematologic toxicity
- Liver failure and kidney failure
- Yellow fever vaccine and other live attenuated vaccines are not recommended for patients receiving gemcitabine
- The risk of cardiac and/or vascular disorders with gemcitabine
- Posterior reversible syndrome (PRES)
- Capillary leak syndrome
- Pulmonary edema, interstitial pneumonia or severe adult respiratory distress syndrome (ARDS).
- Spermatogenesis deficiency
Side Effects:
- Nausea with/without vomiting, increased liver transaminases (AST/ALT) and alkaline phosphatase, occurring in approximately 60% of patients, proteinuria and hematuria occurring. in about 50% of patients; dyspnea in 10-40% of patients (highest rate in lung cancer patients); allergic skin rash occurs in about 25% of patients and is accompanied by pruritus in 10% of patients.
Ingredients:
- Gemcitabine 1000Mg/100ml.
Reviews
There are no reviews yet.